Despite these limitations the results of the present study demonstrate the impact of socioeconomic factors on cystatin C and show that the association is also apparent when cystatin C is used as a subclinical marker in participants without clinical endpoints such as renal impairment, coronary artery disease and stroke. The gene discussed is CST3; the disease is Stroke.